Enterprise Products Partners Dividend Received from Consumer Healthcare JV decreased by 38.9% to $11.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 26.7%, from $15.00M to $11.00M. Over 4 years (FY 2021 to FY 2025), Dividend Received from Consumer Healthcare JV shows an upward trend with a 12.4% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Higher dividends indicate strong performance of the underlying joint venture, contributing positively to the bank's non-interest income.
Cash inflows representing the bank's share of profits distributed from a joint venture or equity-method investment. This...
Specific to companies with equity-method investments; peers report this as income from unconsolidated subsidiaries.
pfe_dividend_received_from_consumer_healthcare_jv| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $18.30M | $4.30M | $5.10M | $11.00M | $44.00M | $27.00M | $16.00M | $15.00M | $15.00M | $7.00M | $5.00M | $15.00M | $24.00M | $25.00M | $13.00M | $15.00M | $20.00M | $21.00M | $18.00M | $11.00M |
| QoQ Change | — | -76.5% | +18.6% | +115.7% | +300.0% | -38.6% | -40.7% | -6.3% | +0.0% | -53.3% | -28.6% | +200.0% | +60.0% | +4.2% | -48.0% | +15.4% | +33.3% | +5.0% | -14.3% | -38.9% |
| YoY Change | — | — | — | — | +140.4% | +527.9% | +213.7% | +36.4% | -65.9% | -74.1% | -68.8% | +0.0% | +60.0% | +257.1% | +160.0% | +0.0% | -16.7% | -16.0% | +38.5% | -26.7% |